State Food and Drug Administration officially listed, the next few changes and the same!

Medical Network April 11 News According to legend, yesterday morning, the former State Food and Drug Administration delisted at the No. 26 Hospital, West Main Street, Xuanwumen, Xicheng District, Beijing.

Then, on the morning of April 10, the unveiling ceremony for the newly formed State Market Supervision Administration was held at the former State Administration for Industry and Commerce on the 8th Sanlihe Dong Road. State Councilor Wang Yong attended the unveiling ceremony.

What will the company do in the transition period in the coming months?

According to previous news, the timetable for the institutional reform of the State Market Supervision Bureau is as follows:

Equipped with members of the departmental leadership team before March 31;

On April 10, the State General Administration of Market Supervision unveiled;

Complete the establishment of the transfer before April 20;

Before May 31, the draft three-draft rule will be submitted;

June 3 before the three plans for approval;

Implement the new three-phase plan before the end of September;

Acceptance at the end of 2018.

As of now, the leadership team has already existed, and both the Market Supervision Bureau and the Food and Drug Administration have also been listed. However, institutional reforms are still in progress. There are still several months away from being in place. During the transition period, companies in the industry have something to do. What is going on?

On April 10, the State Administration of Market Supervision and the State Food and Drug Administration issued a joint report on the issue of food during institutional reforms. drug Notice of Regulatory Work Clearly:

Before the “Sanding” plan was announced, the examination, approval, supervision and inspection, inspection and inspection, inspection and law enforcement, complaints and reports, and information disclosure undertaken by the General Food and Drug Administration were still handled according to the original regulations; Documents such as documents, certificates, and documents are temporarily used in the original format. The business seal and text format used will not be changed for the time being. The processing procedures will not be changed for the time being. After the organization reform is in place, relevant matters will be announced.

That is, in the coming months, everyone will work as they are and there is no need for major adjustments.

On the composition of the market supervision bureau and the leadership of the Food and Drug Administration, an industry observer stated to Sai Bolan that the original CFDA director Bi Jingquan was leading medicine The direction of reform should not change within a few years. At present, as the secretary of the General Administration of Market Supervision, the State Food and Drug Administration is still under its management, and it will play a greater role in macro direction and organizational guarantee, which will facilitate the continuity of the policy. .

Jiao Hong is director of the State Drug Administration Bureau. He has nearly 20 years of experience in pharmaceuticals, health and drug supervision, and is familiar with the industry. During the period when he was deputy director of CFDA, he was responsible for medical instruments The supervision work has been issued, a large number of regulations and documents have been revised, and a large number of industry standards have been issued. The development of the industry has become more orderly and standardized.

Li Li took the post of vice governor as party secretary of the State Food and Drug Administration. Before the vice governor, he worked in medical institutions and health departments for many years and may be familiar with the medical system. This helps the State Food and Drug Administration to become involved in the medical affairs. When it comes to policy, it is more scientific and reasonable.

Then, after the institutional reform, what are the changes and changes in the supervision of pharmaceuticals?

The author believes that in recent years, some of the reform measures mentioned by the State Development and State Development Offices will not easily change, including the review, assessment and approval policies for medicines and medical devices, conformity assessment policies, and generic drug policies, etc. .

The policies concerning sampling of medicines, medical equipment, inspections, and routine inspections may need to be adjusted. Many of the inspections are led by provincial and sub-provincial pharmaceutical supervisors. However, there is no longer a Food and Drug Administration in the province. The situation has changed. .

And according to the new policy, a unified market law enforcement team will be set up, and the original team of inspectors will be set up. It is cause for concern.

In addition, the setting of the department within the national bureau will certainly be compressed. It will not be like this. The future may be another team. It is not yet clear what the final model is.

Tang Minzheng, former deputy director of the Shanghai Municipal Drug Administration, said at the 33rd China Pharmaceutical Industry Development Summit Forum.

As for the change of functions, Tang Minxi said that he looks forward to focusing on risks and scientifically configuring supervision resources.

'Originally there were 60,000 people involved in pharmaceutical supervision. Now that 60,000 people are still in the team, but the functions have changed to the market supervision bureau. We must strengthen the control of the risk component. There is no risk that can be ignored. '

As the superior agency of the State Food and Drug Administration, the new General Market Supervision Bureau has integrated multi-sector anti-monopoly functions. It can be seen that the strength of market supervision and anti-monopoly will be further increased.

Yesterday, at a speech at the Boao Forum for Asia, state leaders stated that in order to create a more attractive investment environment, we will strengthen the interface with international economic and trade rules, enhance transparency, strengthen property rights protection, persist in handling affairs according to law, encourage competition, and oppose monopolization.

In March this year, we formed the State Market Supervision and Administration Bureau, and some other new institutions, made substantial adjustments to existing government agencies, resolutely eliminated the constraints, and made the market play a decisive role in the allocation of resources to better play the role of the government. The institutional mechanism drawbacks. '

This means that the General Directorate of the Market has high hopes for the anti-monopoly function.

At the same time, after the first meeting of the Third Plenary Session of the 18th National Congress of the People's Republic of China proposed that 'the market plays a decisive role in the allocation of resources', including the 19th National Congress of the People's Republic of China, and this speech, the consensus of the whole Party will continue to be strengthened, and the General Administration of Marketing will also promote this. The consensus has played an important role.

Leader: Zhang Mao Bi Jingquan

Deputy Team Leader: Ma Zhengqi Tian Shihong Sun Meijun

Members: Gan Lin Tang Jun Liu Shi Qin Yizhi Chen Gang Shen Changyu

Liu Junchen Li Li Jiao Hong

Work team:

Office Working Group: Tang Jun

Responsible for official document operation, conference security, use of seals, listing, office area adjustment, on-duty work, etc., undertaking the work of the Bureau of the General Administration of Enterprise Reform Leading Group, and the drafting of documents during the reform process.

Members: Yu Fachang Lin Wei Wang Tiehan

'Sanding' Program Working Group: Ma Zhengqi Tian Shihong Sun Meijun Group Leader

Study and Draft Administration Bureau's "Three Sets" plan and report, according to the procedure to do a good job of "three set" for approval.

Members: Fang Yuelin Ding Yifang Wang Shizhong

Party Construction Working Group: Chairman Ma Zhengqi

Responsible for organ party building, do a good job of the political and ideological work of cadres and workers during the reform, and ensure that the ideology is stable.

Members: Wang Shujun Jia Ke Duan Yongsheng

Laws and Regulations Cleanup and Revision Working Group: Qin Yizhi

According to the integration of institutional reform functions, put forward relevant laws and regulations or amend the relevant laws. Regulation Suggestions.

Members: Xu Xinjian Liu Hongliang Xu Jinghe Song Jianhua

Staff Integration and Transferring Working Group: Bi Jingquan

Responsible for the transfer of personnel of the comprehensive department.

Members: Fang Yuelin Ding Yifang Wang Shizhong

Financial Assets Working Group: Tian Shihong, Group Leader

Do a good job in financial reforms such as financial asset management and funding guarantees.

Members: Huang Guansheng Wang Xiaoyan Zhu Weiliang

News and Publicity Working Group: Sun Meijun

Responsible for news and propaganda during institutional reforms, public opinion monitoring, etc.

Members: Yan Jiangyan Huang Jiancheng Han Yunping

Administrative Protection Working Group: Chairman Chen Gang

3. Responsible for office space, institutional catering, vehicle security, agency security, coordination with office area during agency reforms, etc.

Members: Li Haiqing Wang Zhifang Shen Chuanyong Bai Guangqing

Information Technology Support Working Group: Gan Lin

Provides information security for the normal operation of institutions during institutional reforms.

Members: Fu Hongwei Wang Hai Huang Guo Qian Qian

Comprehensive Law Enforcement Working Group: Ma Zhengqi Tian Shihong Sun Meijun Shen Changyu Group Leader

Responsible for the integration and construction of a comprehensive law enforcement team.

Members: Yang Hongcan Yan Fengmin Jiang Deyuan Zhao Meisheng